| Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations KL Becker, R Snider, ES Nylen Critical care medicine 36 (3), 941-952, 2008 | 978 | 2008 |
| Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis B Müller, JC White, ES Nylén, RH Snider, KL Becker, JF Habener The Journal of Clinical Endocrinology & Metabolism 86 (1), 396-404, 2001 | 914 | 2001 |
| Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors KL Becker, ES Nylen, JC White, B Muller, RH Snider Jr The Journal of Clinical Endocrinology & Metabolism 89 (4), 1512-1525, 2004 | 862 | 2004 |
| Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis ES Nylen, KT Whang, RH Snider, PM Steinwald, JC White, KL Becker Critical care medicine 26 (6), 1001-1006, 1998 | 598 | 1998 |
| In Vitro and in Vivo Calcitonin I Gene Expression in Parenchymal Cells: A Novel Product of Human Adipose Tissue P Linscheid, D Seboek, ES Nylen, I Langer, M Schlatter, KL Becker, ... Endocrinology 144 (12), 5578-5584, 2003 | 536 | 2003 |
| Glutamate as a CNS transmitter. I. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate AC Hamberger, GH Chiang, ES Nylén, SW Scheff, CW Cotman Brain research 168 (3), 513-530, 1979 | 499 | 1979 |
| Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target KL Becker, R Snider, ES Nylen British journal of pharmacology 159 (2), 253-264, 2010 | 494 | 2010 |
| Serum calcitonin precursors in sepsis and systemic inflammation KT Whang, PM Steinwald, JC White, ES Nylen, RH Snider, GL Simon, ... The Journal of Clinical Endocrinology & Metabolism 83 (9), 3296-3301, 1998 | 367 | 1998 |
| Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. RH Snider Jr, ES Nylen, KL Becker Journal of investigative medicine: the official publication of the American …, 1997 | 328 | 1997 |
| Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes V Papademetriou, L Lovato, M Doumas, E Nylen, A Mottl, RM Cohen, ... Kidney international 87 (3), 649-659, 2015 | 252 | 2015 |
| Procalcitonin in young febrile infants for the detection of serious bacterial infections V Maniaci, A Dauber, S Weiss, E Nylen, KL Becker, R Bachur Pediatrics 122 (4), 701-710, 2008 | 235 | 2008 |
| Procalcitonin and proinflammatory cytokine interactions in sepsis KT Whang, SD Vath, KL Becker, RH Snider, ES Nylen, B Muller, Q Li, ... Shock 14 (1), 73-78, 2000 | 229 | 2000 |
| Pneumonitis-associated hyperprocalcitoninemia ES Nylen, P Rohatgi, KL Becker, RH Snider Jr, KA Thompson The American journal of the medical sciences 312 (1), 12-18, 1996 | 207 | 1996 |
| Disordered calcium homeostasis of sepsis: association with calcitonin precursors Müller, Kränzlin, Schächinger, Huber, Nylèn, Snider, Zimmerli, Ritz European journal of clinical investigation 30 (9), 823-831, 2000 | 188 | 2000 |
| Serum procalcitonin as an index of inhalation injury in burns ES Nylen, W O'neill, MH Jordan, RH Snider, CF Moore, M Lewis, OL Silva, ... Hormone and metabolic research 24 (09), 439-442, 1992 | 186 | 1992 |
| Bacterial complications of respiratory tract viral illness: a comprehensive evaluation AR Falsey, KL Becker, AJ Swinburne, ES Nylen, MA Formica, ... The Journal of infectious diseases 208 (3), 432-441, 2013 | 180 | 2013 |
| Effect of classic heatstroke on serum procalcitonin ES Nylen, A Al Arifi, KL Becker, RH Snider, A Alzeer Critical care medicine 25 (8), 1362-1365, 1997 | 168 | 1997 |
| Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes P Kokkinos, J Myers, E Nylen, DB Panagiotakos, A Manolis, A Pittaras, ... Diabetes care 32 (4), 623-628, 2009 | 162 | 2009 |
| BMI–mortality paradox and fitness in African American and Caucasian men with type 2 diabetes P Kokkinos, J Myers, C Faselis, M Doumas, R Kheirbek, E Nylen Diabetes Care 35 (5), 1021-1027, 2012 | 139 | 2012 |
| Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis PM Sexton, G Christopoulos, A Christopoulos, ES Nylen, RH Snider Jr, ... Critical care medicine 36 (5), 1637-1640, 2008 | 137 | 2008 |
